SEC Form 4 · accession 0001179110-15-005315
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Narendra D. Lalwani
Officer — Chief Operating Officer
Period of report
Mar 18, 2015
Accepted (ET)
Mar 20, 2015 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $105.72 | Mar 18, 2015 | A | 20,000 | A | — | Mar 18, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F125% of option vests on March 18, 2016 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.